These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34428227)

  • 1. Association of dialysis-related amyloidosis with lower quality of life in patients undergoing hemodialysis for more than 10 years: The Kyushu Dialysis-Related Amyloidosis Study.
    Tsuruya K; Arima H; Iseki K; Hirakata H;
    PLoS One; 2021; 16(8):e0256421. PubMed ID: 34428227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy and safety of the small-sized β2-microglobulin adsorption column for dialysis-related amyloidosis.
    Yamamoto Y; Hirawa N; Yamaguchi S; Ogawa N; Takeda H; Shibuya K; Kawahara K; Kojima H; Dobashi Y; Fujita M; Azusima K; Miyazaki N; Kobayashi M; Kobayashi C; Fujiwara A; Yuto J; Saka S; Yatsu K; Toya Y; Yasuda G; Ohnishi T; Umemura S
    Ther Apher Dial; 2011 Oct; 15(5):466-74. PubMed ID: 21974700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal transplantation relieves the symptoms but does not reverse beta 2-microglobulin amyloidosis.
    Mourad G; Argilés A
    J Am Soc Nephrol; 1996 May; 7(5):798-804. PubMed ID: 8738817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of beta(2)-microglobulin adsorption column on dialysis-related amyloidosis.
    Abe T; Uchita K; Orita H; Kamimura M; Oda M; Hasegawa H; Kobata H; Fukunishi M; Shimazaki M; Abe T; Akizawa T; Ahmad S
    Kidney Int; 2003 Oct; 64(4):1522-8. PubMed ID: 12969174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical staging score to measure the severity of dialysis-related amyloidosis.
    Hoshino J; Kawada M; Imafuku A; Mise K; Sumida K; Hiramatsu R; Hasegawa E; Hayami N; Yamanouchi M; Suwabe T; Sawa N; Ubara Y; Takaichi K
    Clin Exp Nephrol; 2017 Apr; 21(2):300-306. PubMed ID: 27339443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleural involvement of dialysis-related amyloidosis.
    Suzuki M; Betsuyaku T; Kojima T; Saito H; Nishiura Y; Fukasawa Y; Nishimura M; Kawakami Y
    Intern Med; 2005 Jun; 44(6):628-31. PubMed ID: 16020894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance characteristics of a dialysis-related amyloidosis questionnaire.
    Chertow GM; Trimbur T; Karlson EW; Lazarus JM; Kay J
    J Am Soc Nephrol; 1996 Aug; 7(8):1235-40. PubMed ID: 8866418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Historical background and clinical treatment of dialysis-related amyloidosis.
    Yamamoto S; Gejyo F
    Biochim Biophys Acta; 2005 Nov; 1753(1):4-10. PubMed ID: 16226497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of circulating beta2-microglobulin level for the treatment of dialysis-related amyloidosis.
    Kazama JJ; Maruyama H; Gejyo F
    Nephrol Dial Transplant; 2001; 16 Suppl 4():31-5. PubMed ID: 11402095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating level of alpha2-macroglobulin-beta2-microglobulin complex in hemodialysis patients.
    Motomiya Y; Ando Y; Haraoka K; Sun X; Iwamoto H; Uchimura T; Maruyama I
    Kidney Int; 2003 Dec; 64(6):2244-52. PubMed ID: 14633149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-Hours Hemodialysis without Dietary Restrictions Is Associated with Lower Risk for Developing of Dialysis-Related Amyloidosis.
    Tabata S; Kaneda F; Ohwada K; Nishiyama T; Kaneda H
    Tohoku J Exp Med; 2021 Apr; 253(4):241-248. PubMed ID: 33828023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodialysis-related amyloidosis: Is it still relevant?
    Kaneko S; Yamagata K
    Semin Dial; 2018 Nov; 31(6):612-618. PubMed ID: 29896815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of the decreased risk of dialysis-related amyloidosis now proven by results from Japanese nationwide surveys in 1998 and 2010.
    Hoshino J; Yamagata K; Nishi S; Nakai S; Masakane I; Iseki K; Tsubakihara Y
    Nephrol Dial Transplant; 2016 Apr; 31(4):595-602. PubMed ID: 26206763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of advanced dialysis technology on the prevalence of dialysis-related amyloidosis in long-term maintenance dialysis patients.
    Schiffl H
    Hemodial Int; 2014 Jan; 18(1):136-41. PubMed ID: 23718290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological survey and risk factor analysis of dialysis-related amyloidosis including destructive spondyloarthropathy, dialysis amyloid arthropathy, and carpal tunnel syndrome.
    Tagami A; Tomita M; Adachi S; Tsuda K; Yamada S; Chiba K; Okazaki N; Yonekura A; Tsujimoto R; Kajiyama S; Matsubayashi S; Miyamoto T; Mochizuki Y; Ohba K; Osaki M
    J Bone Miner Metab; 2020 Jan; 38(1):78-85. PubMed ID: 31414282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mediators of amyloidogenesis and cytokines in dialysis-related amyloidosis].
    Rysavá R; Merta M; Tesar V; Lachmanová J; Sulková S; Bláha J
    Cas Lek Cesk; 2002 Apr; 141(8):244-7. PubMed ID: 12038073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis-related amyloidosis of the tongue in long-term hemodialysis patients.
    Matsuo K; Nakamoto M; Yasunaga C; Goya T; Sugimachi K
    Kidney Int; 1997 Sep; 52(3):832-8. PubMed ID: 9291206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in understanding dialysis-related amyloidosis.
    Yamamoto S; Kazama JJ; Narita I; Naiki H; Gejyo F
    Bone; 2009 Jul; 45 Suppl 1():S39-42. PubMed ID: 19303954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of the effects of a column for adsorption of β2-microglobulin in patients with dialysis-related amyloidosis in Japan.
    Gejyo F; Amano I; Ando T; Ishida M; Obayashi S; Ogawa H; Ono T; Kanno Y; Kitaoka T; Kukita K; Kurihara S; Sato M; Shin J; Suzuki M; Takahashi S; Taguma Y; Takemoto Y; Nakazawa R; Nakanishi T; Nakamura H; Hara S; Hiramatsu M; Furuya R; Masakane I; Tsuchida K; Motomiya Y; Morita H; Yamagata K; Yoshiya K; Yamakawa T;
    Ther Apher Dial; 2013 Feb; 17(1):40-7. PubMed ID: 23379492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nontransplant therapy for dialysis-related amyloidosis.
    Copley JB; Lindberg JS
    Semin Dial; 2001; 14(2):94-8. PubMed ID: 11264774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.